Neurocognitive Function After Carotid Thrombendarterectomy

Sponsor
Clinical Hospital Centre Zagreb (Other)
Overall Status
Recruiting
CT.gov ID
NCT05739357
Collaborator
(none)
60
1
2
50
1.2

Study Details

Study Description

Brief Summary

Previous studies did not reach a consensus on the influence of the type of anesthesiologic procedure and monitoring, during carotid thrombendarterectomy, on perioperative complications and cognitive outcomes. The aim of this study is the optimization of brain perfusion during the vascular carotid clamp using multimodal monitoring. We assume that standardized monitoring techniques and a better selection of cognitive tests will allow a more accurate assessment of subclinical cognitive deficits.

Condition or Disease Intervention/Treatment Phase
  • Device: NIRS, EEG
N/A

Detailed Description

ABSTRACT:

AIM OF THE STUDY: Effect of perioperative multimodal monitoring with transcranial doppler (TCD), near-infrared spectroscopy (NIRS), and Electroencephalography (EEG) in patients for carotid thrombendarterectomy (CEA) on perioperative complications and cognitive functions.

PATIENTS AND METHODS: The prospective study will analyze 80 consecutive patients with an asymptomatic and symptomatic (transitory ischemic attack, TIA, in anamnesis) stenosis of the internal carotid artery in which CEA is indicated in general anesthesia. Cognitive tests will be analyzed for all patients preoperatively, first and eighth day postoperatively, and after 8 weeks. Breath-holding index (BHI) will be measured preoperatively and postoperatively. The first group of patients (n = 40) will have expanded intraoperative monitoring involving TCD, NIRS, and EEG, and the control group (n = 40) will have only standard anesthetic monitoring.

EXPECTED CONTRIBUTION OF THE STUDY: Previous studies did not agree on the influence of the type of anesthesiologic procedure and monitoring of perioperative complications and cognitive outcomes. We assume that standardized monitoring techniques and a better selection of cognitive tests will allow a more accurate assessment of the effect.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Perioperative Complications and Cognitive Outcome in Carotid Thrombendarterectomy With Multimodal Monitoring Cerebral Perfusion Optimisation
Actual Study Start Date :
Aug 1, 2019
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cerebral perfusion monitoring

Multimodal monitoring includes cerebral oxygenation (with NIRS) and EEG (with SEDLINE). During the carotic clamp, if cerebral oxygenation decreased for more than 12 % on the operating side from the baseline value, simple interventions as, increasing arterial blood pressure, increasing arterial carbon dioxide tension or increasing oxygen inspiration concentration will be performed.

Device: NIRS, EEG
During the carotic clamp, if cerebral oxygenation decreased for more than 12 % on the operating side from the baseline value, simple interventions as, increasing arterial blood pressure, increasing arterial carbon dioxide tension or increasing oxygen inspiration concentration will be performed.
Other Names:
  • cerebral oximetry
  • No Intervention: Control

    The control arm does not have any monitor of cerebral perfusion and oxygenation, during the carotic clamp only intervention is regulating arterial blood pressure values.

    Outcome Measures

    Primary Outcome Measures

    1. Montreal Cognitive Assessment (MoCA) [Change in measurements (result is in numbers) done at four time points (before surgery, day after the surgery, on 7th day and after 8 weeks]

      A widely used screening assessment for detecting cognitive impairment. It was validated in the setting of mild cognitive impairment, and has subsequently been adopted in numerous other settings clinically. This test consists of 30 points and takes part in 10 minutes from the individual. The Montreal test is performed in seven steps. The basics of this test include short-term memory, executable performance, attention, focus and more.

    2. Trail making test (TMT) 1 [Changes in measurements (results are in seconds) done at four time points (before surgery, day after the surgery, on 7th day and after 8 weeks]

      Neuropsychological test that involves visual scanning and working memory. In the TMT-1 (rote memory) the subject is instructed to connect a set of 25 dots as quickly as possible (time is measured in seconds).

    3. Trail making test (TMT) 2 [Changes in measurements done at four time points (before surgery, day after the surgery, on 7th day and after 8 weeks]

      TMT-2 (executive functioning) is a neuropsychological test that involves visual scanning and working memory. In this test the dots go from 1 to 13 and include letters from A to L.

    4. Month backwards test (MBT) [changes in measurements done at four time points (before surgery, day after the surgery, on 7th day and after 8 weeks]

      It is a rapid (< 2 min) and simple to administer test of cognitive function that is widely used at the bedside. The test requests the subject to recite the months of the year in reverse order starting with December, until the subject reaches January.

    Secondary Outcome Measures

    1. Difference in brain reactivity measured by Breath holding index [8 weeks]

      Difference in breath holding index before surgery , after the surgery and after eight weeks as a surrogate of brain perfusion in both groups of patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients with The North American Symptomatic Carotid Endarterectomy Trial (NASCET) stenosis of more than 70%

    • symptomatic stenosis

    • asymptomatic stenosis

    • elective surgery patients

    • signed informed consent

    • initial MoCa test equal and more than 22

    Exclusion Criteria:
    • who refuse to participate

    • previous stroke in anamnesis

    • patient without bone window for BHI measurements

    • comorbidities with aphasia and plegia, and the impossibility to solve cognitive tests

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UHCZagreb Zagreb Croatia 10000

    Sponsors and Collaborators

    • Clinical Hospital Centre Zagreb

    Investigators

    • Principal Investigator: Tina Tomic Mahecic, UHC Zagreb

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tina Tomic Mahecic, Consultant anesthesiologist, Clinical Hospital Centre Zagreb
    ClinicalTrials.gov Identifier:
    NCT05739357
    Other Study ID Numbers:
    • UHCZagreb 02/21 AG
    First Posted:
    Feb 22, 2023
    Last Update Posted:
    Feb 22, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Tina Tomic Mahecic, Consultant anesthesiologist, Clinical Hospital Centre Zagreb
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 22, 2023